Pharmacogenomics

Provides key information needed to choose effective medications and reduce side effects based upon your genomic makeup.

Adverse drug reactions, over-prescribing, under-prescribing, and trial-and-error attempts to identify appropriate medications put patients at risk and waste billions of dollars every year. Pharmacogenomics evaluates genes involved in drug metabolism, transport, and elimination to help identify the medications and dosages that will be most effective with minimal risk of negative side effects. ~99% of the population carries one gene SNP that can affect medication response, and 89% carry two or more. A proactive, pharmacogenomics approach helps to identify how an individual may process prescription and over-the-counter medications. These DNA-informed decisions help to identify the right drug at the right dosage—tailored to an individual’s genomic predispositions and specific biochemistry.

This comprehensive pharmacogenomics profile analyzes 44 genes and 372 variants involved in processing over 240 medications, in areas including:

Cancer, Cardiovascular Disease, Diabetes, Gastrointestinal, Gaucher Disease, Infections, Pain, Psychotropic, Rheumatology, Sjogren’s Syndrome, Transplantation, and Urologicals.